Philadelphia-positive leukemias, including CML and some ALL cases, possess the BCR-ABL fusion protein, which originates from the chromosome translocation t(9;22). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.